| Oncimmune (USA) LLC, founded in 2006, is an industry leader in early cancer detection. The company is committed to advancing early cancer detection through proprietary autoantibody assay technologies based on biological technology identified by John Robertson, M.D., Professor of Surgery at Nottingham |
